Send to

Choose Destination
Int J Pediatr Otorhinolaryngol. 2010 Aug;74(8):959-61. doi: 10.1016/j.ijporl.2010.05.013. Epub 2010 Jun 16.

Management of infantile subglottic hemangioma: acebutolol or propranolol?

Author information

ENT Department, CHU Montpellier, France.


The successful management of subglottic hemangioma with propranolol has been reported. We report three cases of subglottic hemangioma treated with the cardioselective beta-blocker acebutolol, 8 mg/kg/day. Treatment was efficient in two cases while an open procedure was necessary in the third child. In our experience, acebutolol could be easily administered in oral form twice-a-day only with a dose that was adaptable according to the growth of the child and showed no side effects. We also report a case of rebound growth after beta-mimetic drug use and the efficiency of propranolol treatment in such a recurrence. Considering the lack of side effects and the advantages in terms of administration, we suggest acebutolol as a first-line treatment of subglottic hemangiomas for which intervention is required.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center